Update on operations during COVID-19 period
Updated on May 21st, 2020
During recent weeks, we received many inquires regarding our operations during the coronavirus pandemic. Fortunately, both our primary sites are located in the Northern part of Europe and are fully operational. We have adopted additional safeguards to protect our personnel, including transitioning all non-research personal to telecommuting.
As many universities across the United States and in some European and Asian countries are closed, we are aware of the difficulties this is placing on maintaining productivity on grant-funded projects. Therefore, we would like to remind our colleagues from academia that we are here for you to help! If you are interested in outsourcing your in vitro and in vivo studies, please get in touch with us and discuss an opportunity to advance your studies at Experimentica! We have special academic pricing in place to help you through this pandemic.
Experimentica Ltd. is a contract research organization (ophthalmic CRO) dedicated to developing and offering novel preclinical ocular models and services to clients in the pharmaceutical, biotech and academic sectors.
We offer the preclinical development pipeline with an industry leading portfolio of in vitro, ex vivo and in vivo models. Choose one of the categories below to learn more:
Thank you for all of your excellent work. I’ve done about 6 or 7 studies with various CRO's over the past year. The breadth of your technical capabilities, scientific expertise, communication, speed, and quality of the report and output far exceeds anything I have received in other collaborations.
Switzerland-based biotech company
After discussing dry eye models with several organizations, the expertise at Experimentica stood out head and shoulders above the rest. The care and detail of your model, your insight into the disease and ability to understand our particular mechanism and needs was excellent.
US-based biotech company
I wanted to personally thank you for all your help and support over the last two years. We certainly did some great work together, and I look forward to working with you on future projects.
US-based biotech company
Experimentica’s team was instrumental in the training of our clinician-scientists by offering internship opportunities and research support. We are impressed by the quality of your work and the in-depth scientific knowledge of your entire team. I look forward to continuing this successful collaboration.
Professor and Chair of Ophthalmology, Academic Medical Center, European Union
A synthetic metalloporphyrin SOD mimetic protects corneal epithelial cells from oxidative stress-induced damage in vitro and in vivo
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!